Beyond Mere Diversity: Tailoring Combinatorial Libraries for Drug Discovery

Citations Over TimeTop 1% of 1998 papers

Abstract

Combinatorial library design attempts to choose the best set of substituents for a combinatorial synthetic scheme to maximize the chances of finding a useful compound, such as a drug lead. Initial efforts were focused primarily on maximizing diversity, perhaps allowing some bias by the inclusion of a small, fixed set of pharmacophoric substituents. However, many factors besides diversity impact good library design for drug discovery. A library can be better "tailored" by assigning the candidate substituents to categories such as polar, pharmacophoric, rigid, low molecular weight, and expensive. Stratified sampling by successive steps of D-optimal design generates diverse designs which are also consistent with desirable profiles of these properties. Comparing the diversity scores among design profiles reveals the tradeoffs between diversity, physical property distributions, synthetic difficulty, expense, and pharmacophoric bias. The diversity scores can be calibrated by scoring the best designs from subsets of the candidates made either from specific classes of substituents or by randomly eliminating candidates. This procedure shows how poor random designs are compared even to highly biased optimal designs. Library design requires a synergistic effort between computational and synthetic medicinal chemists, so specialized interactive software has been developed to integrate substructure searching, display, and statistical experimental design to facilitate this interaction for the effective design of well-tailored libraries.

Related Papers

• → A Diastereoselective Synthesis of 2,4-Disubstituted Piperidines: Scaffolds for Drug Discovery(2000)312 cited
• → Synthesis and evaluation of paclitaxel C7 derivatives: Solution phase synthesis of combinatorial libraries(1998)23 cited
• Combinatorial parallel synthesis of biologically active libraries on soluble polymer supports(2003)
• Recent Advance in Solution - Phase Combinatorial Synthesis(2000)
• → Solid Phase Synthesis of 1,2,4-Triazinan-3-ones(2001)